Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus

R. Michael Siatkowski, Ingrid U. Scott, Alan M. Verm, Ann A. Warn, Bradley K. Farris, Mitchell B. Strominger, Evelyn Sklar

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Purpose To report the clinical presentation of acute visual loss in six patients who were ultimately diagnosed with systemic lupus erythematosus (SLE). Methods Retrospective case series. Results All patients had a positive antinuclear antibody and elevated anti-double stranded DNA titers. Five of six patients demonstrated gadolinium enhancement of the optic nerve and/or chiasm on magnetic resonance imaging (MRI). Most patients showed initial improvement after treatment with high-dose systemic corticosteroids, but five experienced recrudescences during steroid taper, requiring further treatment with immunosuppressive or cytotoxic medications. Conclusions Visual loss owing to optic neuropathy or chiasmopathy may be the presenting sign of SLE or the event that leads to this diagnosis. Gadolinium-enhanced MRI is useful for identifying anterior visual pathway lesions in these patients. Corticosteroids are effective in the treatment of this condition; however, relapses requiring further treatment are common.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalJournal of Neuro-Ophthalmology
Volume21
Issue number3
StatePublished - 2001

Fingerprint

Optic Nerve Diseases
Systemic Lupus Erythematosus
Gadolinium
Adrenal Cortex Hormones
Magnetic Resonance Imaging
Optic Chiasm
Recurrence
Visual Pathways
Antinuclear Antibodies
Therapeutics
Immunosuppressive Agents
Optic Nerve
Steroids
DNA

Keywords

  • Optic chiasm
  • Optic neuropathy
  • Septemic eupus eripthematosus
  • Vision loss

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology

Cite this

Michael Siatkowski, R., Scott, I. U., Verm, A. M., Warn, A. A., Farris, B. K., Strominger, M. B., & Sklar, E. (2001). Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. Journal of Neuro-Ophthalmology, 21(3), 193-198.

Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. / Michael Siatkowski, R.; Scott, Ingrid U.; Verm, Alan M.; Warn, Ann A.; Farris, Bradley K.; Strominger, Mitchell B.; Sklar, Evelyn.

In: Journal of Neuro-Ophthalmology, Vol. 21, No. 3, 2001, p. 193-198.

Research output: Contribution to journalArticle

Michael Siatkowski, R, Scott, IU, Verm, AM, Warn, AA, Farris, BK, Strominger, MB & Sklar, E 2001, 'Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus', Journal of Neuro-Ophthalmology, vol. 21, no. 3, pp. 193-198.
Michael Siatkowski R, Scott IU, Verm AM, Warn AA, Farris BK, Strominger MB et al. Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. Journal of Neuro-Ophthalmology. 2001;21(3):193-198.
Michael Siatkowski, R. ; Scott, Ingrid U. ; Verm, Alan M. ; Warn, Ann A. ; Farris, Bradley K. ; Strominger, Mitchell B. ; Sklar, Evelyn. / Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. In: Journal of Neuro-Ophthalmology. 2001 ; Vol. 21, No. 3. pp. 193-198.
@article{70e7eb80eea84ca8a4ee7cef7d8fad3f,
title = "Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus",
abstract = "Purpose To report the clinical presentation of acute visual loss in six patients who were ultimately diagnosed with systemic lupus erythematosus (SLE). Methods Retrospective case series. Results All patients had a positive antinuclear antibody and elevated anti-double stranded DNA titers. Five of six patients demonstrated gadolinium enhancement of the optic nerve and/or chiasm on magnetic resonance imaging (MRI). Most patients showed initial improvement after treatment with high-dose systemic corticosteroids, but five experienced recrudescences during steroid taper, requiring further treatment with immunosuppressive or cytotoxic medications. Conclusions Visual loss owing to optic neuropathy or chiasmopathy may be the presenting sign of SLE or the event that leads to this diagnosis. Gadolinium-enhanced MRI is useful for identifying anterior visual pathway lesions in these patients. Corticosteroids are effective in the treatment of this condition; however, relapses requiring further treatment are common.",
keywords = "Optic chiasm, Optic neuropathy, Septemic eupus eripthematosus, Vision loss",
author = "{Michael Siatkowski}, R. and Scott, {Ingrid U.} and Verm, {Alan M.} and Warn, {Ann A.} and Farris, {Bradley K.} and Strominger, {Mitchell B.} and Evelyn Sklar",
year = "2001",
language = "English (US)",
volume = "21",
pages = "193--198",
journal = "Journal of Neuro-Ophthalmology",
issn = "1070-8022",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus

AU - Michael Siatkowski, R.

AU - Scott, Ingrid U.

AU - Verm, Alan M.

AU - Warn, Ann A.

AU - Farris, Bradley K.

AU - Strominger, Mitchell B.

AU - Sklar, Evelyn

PY - 2001

Y1 - 2001

N2 - Purpose To report the clinical presentation of acute visual loss in six patients who were ultimately diagnosed with systemic lupus erythematosus (SLE). Methods Retrospective case series. Results All patients had a positive antinuclear antibody and elevated anti-double stranded DNA titers. Five of six patients demonstrated gadolinium enhancement of the optic nerve and/or chiasm on magnetic resonance imaging (MRI). Most patients showed initial improvement after treatment with high-dose systemic corticosteroids, but five experienced recrudescences during steroid taper, requiring further treatment with immunosuppressive or cytotoxic medications. Conclusions Visual loss owing to optic neuropathy or chiasmopathy may be the presenting sign of SLE or the event that leads to this diagnosis. Gadolinium-enhanced MRI is useful for identifying anterior visual pathway lesions in these patients. Corticosteroids are effective in the treatment of this condition; however, relapses requiring further treatment are common.

AB - Purpose To report the clinical presentation of acute visual loss in six patients who were ultimately diagnosed with systemic lupus erythematosus (SLE). Methods Retrospective case series. Results All patients had a positive antinuclear antibody and elevated anti-double stranded DNA titers. Five of six patients demonstrated gadolinium enhancement of the optic nerve and/or chiasm on magnetic resonance imaging (MRI). Most patients showed initial improvement after treatment with high-dose systemic corticosteroids, but five experienced recrudescences during steroid taper, requiring further treatment with immunosuppressive or cytotoxic medications. Conclusions Visual loss owing to optic neuropathy or chiasmopathy may be the presenting sign of SLE or the event that leads to this diagnosis. Gadolinium-enhanced MRI is useful for identifying anterior visual pathway lesions in these patients. Corticosteroids are effective in the treatment of this condition; however, relapses requiring further treatment are common.

KW - Optic chiasm

KW - Optic neuropathy

KW - Septemic eupus eripthematosus

KW - Vision loss

UR - http://www.scopus.com/inward/record.url?scp=85013923104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013923104&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85013923104

VL - 21

SP - 193

EP - 198

JO - Journal of Neuro-Ophthalmology

JF - Journal of Neuro-Ophthalmology

SN - 1070-8022

IS - 3

ER -